<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD>
<TITLE>SCD FAQ - azulfidine sulfasalazine, Dr. Present's instructions</TITLE>
<script language="JavaScript">
<!--

function MM_swapImgRestore() { //v2.0
  if (document.MM_swapImgData != null)
    for (var i=0; i<(document.MM_swapImgData.length-1); i+=2)
      document.MM_swapImgData[i].src = document.MM_swapImgData[i+1];
}

function MM_preloadImages() { //v2.0
  if (document.images) {
    var imgFiles = MM_preloadImages.arguments;
    if (document.preloadArray==null) document.preloadArray = new Array();
    var i = document.preloadArray.length;
    with (document) for (var j=0; j<imgFiles.length; j++) if (imgFiles[j].charAt(0)!="#"){
      preloadArray[i] = new Image;
      preloadArray[i++].src = imgFiles[j];
  } }
}

function MM_swapImage() { //v2.0
  var i,j=0,objStr,obj,swapArray=new Array,oldArray=document.MM_swapImgData;
  for (i=0; i < (MM_swapImage.arguments.length-2); i+=3) {
    objStr = MM_swapImage.arguments[(navigator.appName == 'Netscape')?i:i+1];
    if ((objStr.indexOf('document.layers[')==0 && document.layers==null) ||
        (objStr.indexOf('document.all[')   ==0 && document.all   ==null))
      objStr = 'document'+objStr.substring(objStr.lastIndexOf('.'),objStr.length);
    obj = eval(objStr);
    if (obj != null) {
      swapArray[j++] = obj;
      swapArray[j++] = (oldArray==null || oldArray[j-1]!=obj)?obj.src:oldArray[j];
      obj.src = MM_swapImage.arguments[i+2];
  } }
  document.MM_swapImgData = swapArray; //used for restore
}
//-->
</script>
<meta name="keywords" content="Azulfidine,Sulfasalazine, Dr. Present, Pentasa, ">
<meta name="description" content="SCD listserve archive.  Attain remission in Inflammatory Bowel Disease, Ulcerative Colitis, or Crohn's Disease. Research: eliminate specific carbos yields remission in Crohn's, Colitis, and IBD.">
</HEAD>
<BODY aLink=#d5ae83 bgColor=#ffffff leftMargin=0 link=#003366 text=#000000 
topMargin=0 vLink=#003366 marginheight="0" marginwidth="0" onLoad="MM_preloadImages('../images/menu4b_.jpg','#949845008283');MM_preloadImages('../images/menu4c_.jpg','#949845008284');MM_preloadImages('../images/menu4d_.jpg','#949845327750');MM_preloadImages('../images/menu4e_.jpg','#949845327751');MM_preloadImages('../images/menu4f_.jpg','#949845327752');MM_preloadImages('../images/menu4g_.jpg','#949845327753');MM_preloadImages('../images/menu4h_.jpg','#949845327754');MM_preloadImages('../images/menu4i_.jpg','#949845686400');MM_preloadImages('../images/menu4k_.jpg','#957116034816')">
<table border=0 cellpadding=0 cellspacing=0 height="100%" width="82%">
  <tr valign=top> 
    <td bgcolor=#003366 rowspan=2 width="1%" height="1059"> 
      <table bgcolor=#ffffff border=0 cellpadding=0 cellspacing=0 
        width="100%">
        <tbody> 
        <tr> 
          <td align=left><a href="../index.html"><img src="../images/menu4a.jpg" width="120" height="157" border="0"></a><br>
            <a href="../1about" onMouseOut="MM_swapImgRestore()" onMouseOver="MM_swapImage('document.Image_b','document.Image_b','../images/menu4b_.jpg','#949845008283')"><img name="Image_b" border="0" src="../images/menu4b.jpg" width="120" height="17"></a><br>
            <a href="../2recipes" onMouseOut="MM_swapImgRestore()" onMouseOver="MM_swapImage('document.Image_c','document.Image_c','../images/menu4c_.jpg','#949845008284')"><img name="Image_c" border="0" src="../images/menu4c.jpg" width="120" height="17"></a><br>
            <a href="../3testimonials" onMouseOut="MM_swapImgRestore()" onMouseOver="MM_swapImage('document.Image_d','document.Image_d','../images/menu4d_.jpg','#949845327750')"><img name="Image_d" border="0" src="../images/menu4d.jpg" width="120" height="17"></a><br>
            <a href="../4faq" onMouseOut="MM_swapImgRestore()" onMouseOver="MM_swapImage('document.Image_e','document.Image_e','../images/menu4e_.jpg','#949845327751')"><img name="Image_e" border="0" src="../images/menu4e.jpg" width="120" height="16"></a><br>
            <a href="../5community" onMouseOut="MM_swapImgRestore()" onMouseOver="MM_swapImage('document.Image_f','document.Image_f','../images/menu4f_.jpg','#949845327752')"><img name="Image_f" border="0" src="../images/menu4f.jpg" width="120" height="16"></a><br>
            <a href="../6research" onMouseOut="MM_swapImgRestore()" onMouseOver="MM_swapImage('document.Image_g','document.Image_g','../images/menu4g_.jpg','#949845327753')"><img name="Image_g" border="0" src="../images/menu4g.jpg" width="120" height="16"></a><br>
            <a href="../7archives" onMouseOut="MM_swapImgRestore()" onMouseOver="MM_swapImage('document.Image_h','document.Image_h','../images/menu4h_.jpg','#949845327754')"><img name="Image_h" border="0" src="../images/menu4h.jpg" width="120" height="16"></a><br>
            <a href="../8resources" onMouseOut="MM_swapImgRestore()" onMouseOver="MM_swapImage('document.Image_i','document.Image_i','../images/menu4i_.jpg','#949845686400')"><img name="Image_i" border="0" src="../images/menu4i.jpg" width="120" height="16"></a><br>
            <a href="../1about/search.html" onMouseOut="MM_swapImgRestore()" onMouseOver="MM_swapImage('document.Image16','document.Image16','../images/menu4k_.jpg','#957116034816')"><img name="Image16" border="0" src="../images/menu4k.jpg" width="120" height="16"></a><br>
            <img src="../images/menu4n.jpg" width="120" height="121" border="0"></td>
        </tr>
        </tbody> 
      </table>
      <div align="center"><a href="../1about/feedback.html"><font color=#ffffff 
      size=-1><font size="3" face="Arial, Helvetica, sans-serif"><b><font color="#999999"><i>Feedback</i></font></b></font></font></a><br>
        <br>
        <!-- #BeginLibraryItem "/Library/advt.lbi" --><p align="center"><!--#include virtual="/cgi-bin/adrotator/display.cgi" --></p>
<!-- #EndLibraryItem --> 
      </div>
      <center>
        <p><br>
        </p>
        <p>&nbsp;</p>
        <p>&nbsp;</p>
        <p>&nbsp; </p>
      </center>
    </td>
    <td rowspan=2 height="1059">&nbsp;&nbsp;&nbsp;&nbsp;</td>
    <td rowspan=2 width="100%" height="1059"> 
      <p> 
      <table border=0 cellpadding=2 cellspacing=0 width="100%">
        <tr valign=top> 
          <td align=middle bgcolor=#ffffff colspan="2" height="65"> 
            <table border=0 cellpadding=0 cellspacing=0 width="83%">
              <tbody> 
              <tr> 
                <td colspan=3 height="9"> 
                  <p><img alt="" src="../images/upper_left2.gif" width="27" height="11"><img 
                  alt="" src="../images/upper_right2.gif" width="33" height="11"></p>
                </td>
              </tr>
              <tr> 
                <td valign=top><img alt="" src="../images/leftbow.gif" width="27" height="28"></td>
                <td align=left valign=top width="100%"><font face="Arial, Helvetica, sans-serif" size="5"><b><font color="#336699" size="6"><i><font size="5" color="#003366">SCD 
                  FAQ Section</font></i></font></b></font><font color="#336699" size="+2"> 
                  </font></td>
              </tr>
              </tbody> 
            </table>
            <p align="left">&nbsp;</p>
          </td>
        </tr>
        <tr valign=top> 
          <td align=middle bgcolor=#ffffff width="78%"> 
            <table cellpadding=0 cellspacing=0 width="100%">
              <tr> 
                <td valign=top width="95%"> 
                  <TABLE width=100%>
                    <tr bgcolor="#003366"> 
                      <td height="25"> &nbsp; <b><font color="#FFFFFF" face="Arial, Helvetica, sans-serif" size="4"> 
                        Azulfidine (sulfasalazine)</font></b></TD>
                    </TR>
                  </TABLE>
                </td>
                <td bgcolor=#FFFFFF rowspan="2" width="5%">&nbsp; </td>
              </tr>
              <tr> 
                <td bgcolor=#FFFFFF valign="top" height="133" width="95%"> 
                  <p><font size="3" face="Arial, Helvetica, sans-serif"><b>SCD 
                    discussion often centers around the benefits and effects of 
                    prescribed drugs. The following post centers around Dr. Present's 
                    article on Azulfidine, and includes Elaine Gottschall's highlighted 
                    notes (bold) regarding desensitization</b></font><font size="3" face="Arial, Helvetica, sans-serif"><b>. 
                    </b></font></p>
                  <p><font size="3" face="Arial, Helvetica, sans-serif"><b>In 
                    short, Elaine prefers Azulfidine over Asacol.</b></font></p>
                  <p><font face="Arial, Helvetica, sans-serif" size="2"><font color="#000000"> 
                    </font></font></p>
                  </td>
              </tr>
              <tr> 
                <td bgcolor=#FFFFFF colspan="2" valign="top" height="14"> 
                  <p><font size=1>&nbsp; </font></p>
                </td>
              </tr>
              <tr> 
                <td width="95%"> 
                  <table width="100%" border="0" cellspacing="0" cellpadding="0">
                    <tr> 
                      <td width="2%" bgcolor=#336699 valign=top height="21" align="left"><img src="../images/bboxlef2.gif" width="8" height="10" align="top"></td>
                      <td width="98%" bgcolor=#336699 valign=top height="21" align="left"> 
                        <b><font color="#FFFFFF" face="Arial, Helvetica, sans-serif" size="3"> 
                        <img src="../images/arrow.gif" width="13" height="13" border="0" align="texttop"></font> 
                        <font color="#FFFFCC" face="Arial, Helvetica, sans-serif" size="3"> 
                        Sulfasalazine</font></b></td>
                    </tr>
                  </table>
                </td>
              </tr>
              <tr> 
                <td bgcolor=#FFFFFF valign="top" width="95%" height="811"> 
                  <p><font color="#999999" face="Arial, Helvetica, sans-serif" size="2">From: 
                    Deanna<br>
                    Date: Aug 2000</font>&nbsp;</p>
                  <p> <font face="Arial, Helvetica, sans-serif" size="3"> <!--This is where the text begins:--> 
                    <font size="2">From Current Trends in Gastroenterology - 1984-85 
                    <br>
                    &quot;Specific Drug Management&quot; by Dr. Daniel Present</font></font> 
                  </p>
                  <p><font face="Arial, Helvetica, sans-serif" size="2">The official 
                    drug of choice for the management of mild to moderate Crohn's 
                    colitis is sulfasalazine (Azulfidine). This drug is an azo-bonded 
                    combination of sulfapyridine and 5-aminosalicylic acid. The 
                    compound is split by bacteria in the colon (or possible small 
                    bowel, if colonic type microflora are present). At present 
                    the 5-aminosalicylic compound is believed to be the active 
                    agent. The mechanism of action of sulfasalazine is uncertain. 
                    Speculation has centered on its affinity for colonic connective 
                    tissue and sensoral membranes, its anti-inflammatory effects, 
                    and its inhibitory effect on prostaglandin synthesis. The 
                    anti-inflammatory effects may be related to the blockage of 
                    synthesis of products of the lipoxygenase pathway (responsible 
                    for bringing inflammatory cells into areas of the bowel). 
                    Although immunosuppressive factors have been cited, they may 
                    be less important with recent observations that sulfasalazine 
                    and its components do not alter T-cells, immunoglobulin-bearing 
                    B-cells, or skin test responses. </font></p>
                  <p><font face="Arial, Helvetica, sans-serif" size="2">In mild 
                    to moderate cases of Crohn's disease, sulfasalazine therapy 
                    should be instituted gradually, initially 1 to 2 tablets (500 
                    mg) daily and increased by 500 mg doses to 2 to 4 g daily. 
                    Sulfasalazine should be administered in four divided doses, 
                    with meals and with a light snack at night. Although there 
                    are numerous clinicians who advise dosages up to 12 g each 
                    day, I have found that the evidence of side-effects precludes 
                    this level of medication in most patients. Side-effects are 
                    often dose related, reflect serum sulfapyridine levels, which 
                    can be identified in individual patients and then used as 
                    a guide to the dosage of sulfasalazine. Nausea and headache, 
                    the earliest side-effects, can be alleviated by temporarily 
                    lowering the dosage. To avoid the development of upper gastrointestinal 
                    side- effects (heartburn, epigastric discomfort), the coated 
                    tablet (Azulfidine-EN) can be used. Such allergic manifestations 
                    as skin rashes and fevers are not uncommon, but do not constitute 
                    a contradiction to further usage of sulfasalazine. My colleague, 
                    Burton Korelitz, and I have demonstrated that approximately 
                    90 percent of patients with Crohn's disease who have allergic 
                    reactions to sulfasalazine can be successfully desensitized. 
                    ****<b>We use initial dosages of one-eighth to one-fourth 
                    tablet daily for one week, with subsequent doubling of dosages 
                    on a weekly basis until all patients reach therapeutic dosage. 
                    For example, we give one-fourth of a tablet daily for one 
                    week, then one-half tablet daily for one week, then one tablet 
                    daily for one week, and so on. Approximately three of four 
                    patients have shown clinical improvement following desensitization. 
                    Additional information on desensitization is provided in the 
                    chapter on ulcerative colitis therapy.</b>**** </font></p>
                  <p><font face="Arial, Helvetica, sans-serif" size="2">Folate 
                    Deficiency is frequently encountered with sulfasalazine therapy 
                    and requires folic acid supplementation (1 to 3 mg per day). 
                    Other severe complications are rare and include bone marrow 
                    depression, hepatotoxicity, "sulfasalazine lung," and pericarditis. 
                    Hemolyticanemia is not a rare complication, but fortunately 
                    the drug does not always have to be discontinued, and hemolysis 
                    may improve with lowering of the dosage of sulfasalazine. 
                    </font></p>
                  <p><font face="Arial, Helvetica, sans-serif" size="2">(There 
                    was an additional short paragraph on sulfasalaine's possible 
                    effects on male fertility) </font></p>
                  <p><font face="Arial, Helvetica, sans-serif" size="2">-- Deanna 
                    G</font> </p>
                  <p><font face="Arial, Helvetica, sans-serif" size="2"><nobr><a 
                  href="http://www.healingcrow.com/scdwisdom/scdwisdom.html" 
                  style="TEXT-DECORATION: none"><img alt="|>" border=0 
                  src="../images/blackarrow.gif" width="8" height="9">&nbsp;<font 
                  color=#b75a3e><b>more about Azulfidine - on HealingCrow.com</b></font></a></nobr> 
                    </font></p>
                  <p><font face="Arial, Helvetica, sans-serif" size="2"><b>Another 
                    example of someone who switched back to Sulpha:</b></font></p>
                  <p><font face="Arial, Helvetica, sans-serif" size="2" color="#999999">Subject: 
                    Elaine was right! <br>
                    Date: Thu, 26 Apr 2001</font></p>
                  <p><font face="Arial, Helvetica, sans-serif" size="2">Hi, everyone! 
                    This is Lisa, mom to the wonderful, brave and beautiful Olivia, 
                    who is 11 and was diagnosed with Crohn's Disease at the end 
                    of March. </font></p>
                  <p><font face="Arial, Helvetica, sans-serif" size="2">I am writing 
                    to say that, as usual, Elaine was right. Here's the story: 
                    we visited a new pediatric GI on Monday, and he switched Olivia 
                    from sulfasalazine to Pentasa. He told us that Pentasa was 
                    better because it refined (my word, but his meaning) the way 
                    sulfasalazine worked, eliminating the sulfa (or cutting it 
                    down) and emphasizing the salicylates that actually helped 
                    cut down on the inflammation that is part and parcel of Crohn's. 
                    </font></p>
                  <p><font face="Arial, Helvetica, sans-serif" size="2">Elaine 
                    (and others, too!) suggested I read Dr. Present's statements 
                    about sulfasalazine, and indicated that sulfasalazine is actually 
                    the better medication for CD. Several people expressed concern 
                    that Olivia would actually get worse on Pentasa. </font></p>
                  <p><font face="Arial, Helvetica, sans-serif" size="2">Bingo! 
                    She began the Pentasa on Tuesday and by the next day, was 
                    up from one bowel movement a day to two. This morning, for 
                    the first time in the three plus weeks since she started on 
                    SCD and sulfasalazine, she had to hurry to the restroom for 
                    her second bm of the day. She also has a bit of bloating, 
                    gas and looks paler. On the way to my office today (it is 
                    "Take Your Child To Work Day") she felt sick to her stomach 
                    ... again, for the first time in weeks. (On Saturday last, 
                    before we started Pentasa, we rode 40 minutes to a school 
                    where she was to sing in a concert, and she was fine and happy 
                    the whole way.) </font></p>
                  <p><font face="Arial, Helvetica, sans-serif" size="2">I have 
                    already called the doctor to let him know that we are switching 
                    back to sulfasalazine .... the reason I even let him know 
                    is that I want sulfasalazine in pill form, because Olivia 
                    really hates the gloppy orange flavored liquid that we have 
                    at home. Now that I know it is available in pill form, I intend 
                    to have him call in a prescription. </font></p>
                  <p><font face="Arial, Helvetica, sans-serif" size="2">So, folks, 
                    once again you were right! Thank goodness we have Elaine and 
                    SCD and all of you. It is become clearer and clearer who *really* 
                    knows what's what with getting these IBDs under control and 
                    even cured, and it ain't the guys in the white coats. </font></p>
                  <p><font face="Arial, Helvetica, sans-serif" size="2">Love and 
                    good health to all, Lisa in Baltimore <br>
                    Mom of Olivia, 11, CD, SCD three weeks and counting ....</font></p>
          </td>
              </tr>
            </table>
            
          </td>
          <td width="22%"> 
            <p>&nbsp; </p>
            <p>&nbsp;</p>
            <p>&nbsp;</p>
          </td>
        </tr>
      </table>
    </td>
  </tr>

</table>
<TABLE border=0 cellPadding=0 cellSpacing=0 width="82%">
  <TBODY> 
  <TR vAlign=top>
    <TD align=left> 
      <div align="right"><font face="Arial, Helvetica, sans-serif" size="1">Updated: <!--#echo var="LAST_MODIFIED"--></font><a href="../index.html"><img src="../images/footer.jpg" width="391" height="21" border="0"></a></div>
    </TD>
    <TD align=right>&nbsp;</TD>
  </TR></TBODY></TABLE>
</BODY></HTML>
